ES528000A0 - Un procedimiento para la purificacion de un antigeno. - Google Patents

Un procedimiento para la purificacion de un antigeno.

Info

Publication number
ES528000A0
ES528000A0 ES528000A ES528000A ES528000A0 ES 528000 A0 ES528000 A0 ES 528000A0 ES 528000 A ES528000 A ES 528000A ES 528000 A ES528000 A ES 528000A ES 528000 A0 ES528000 A0 ES 528000A0
Authority
ES
Spain
Prior art keywords
antigen
purification
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES528000A
Other languages
English (en)
Other versions
ES8506902A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hybritech Inc
Original Assignee
Hybritech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hybritech Inc filed Critical Hybritech Inc
Publication of ES528000A0 publication Critical patent/ES528000A0/es
Publication of ES8506902A1 publication Critical patent/ES8506902A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES528000A 1982-04-12 1983-12-13 Un procedimiento para la purificacion de un antigeno. Expired ES8506902A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US36778182A 1982-04-12 1982-04-12

Publications (2)

Publication Number Publication Date
ES528000A0 true ES528000A0 (es) 1985-08-01
ES8506902A1 ES8506902A1 (es) 1985-08-01

Family

ID=23448565

Family Applications (3)

Application Number Title Priority Date Filing Date
ES521371A Granted ES521371A0 (es) 1982-04-12 1983-04-11 Un procedimiento para la purificacion de un anticuerpo.
ES528000A Expired ES8506902A1 (es) 1982-04-12 1983-12-13 Un procedimiento para la purificacion de un antigeno.
ES528001A Expired ES8706964A1 (es) 1982-04-12 1983-12-13 Un procedimiento para fraccionar anticuerpos de suero.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES521371A Granted ES521371A0 (es) 1982-04-12 1983-04-11 Un procedimiento para la purificacion de un anticuerpo.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES528001A Expired ES8706964A1 (es) 1982-04-12 1983-12-13 Un procedimiento para fraccionar anticuerpos de suero.

Country Status (11)

Country Link
EP (1) EP0105359A4 (es)
AT (1) AT393386B (es)
AU (1) AU622099B2 (es)
CA (1) CA1209907A (es)
CH (1) CH672028A5 (es)
DK (1) DK192191D0 (es)
ES (3) ES521371A0 (es)
FI (1) FI88403C (es)
GB (1) GB2128630B (es)
IT (1) IT1219779B (es)
WO (1) WO1983003678A1 (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8328918D0 (en) * 1983-10-28 1983-11-30 Unilever Plc Alkaline phosphatase
GB8331071D0 (en) * 1983-11-22 1983-12-29 Karayiannis P Assay for dna/rna
US4666865A (en) * 1984-01-13 1987-05-19 Centocor, Inc. Immunoassay for biologically active human interferon-gamma employing unique monoclonal antibodies
US4789631A (en) * 1984-02-17 1988-12-06 Synbiotics Corporation Immunoassay for anti-dirofilaria immitis antibody
GB8426468D0 (en) * 1984-10-19 1984-11-28 Technology Licence Co Ltd Monoclonal antibodies
AU5259786A (en) * 1985-01-30 1986-08-07 United States Of America, The Monoclonal antibodies against chlamydial genes specific lipopolysaccharide
US4859611A (en) * 1985-02-28 1989-08-22 Massachusetts Institute Of Technology Affinity column and process for detection of low molecular weight toxic substances
US4818687A (en) * 1985-02-28 1989-04-04 Massachusetts Institute Of Technology Affinity column and process for detection of low molecular weight toxic substances
IL75828A (en) * 1985-07-17 1991-06-10 Univ Ramot Immobilization by biologically active proteins
NZ218336A (en) * 1985-12-09 1991-08-27 Kirin Amgen Inc Monoclonal antibodies to human pluripotent granulocyte colony stimulating factor (hpg-csf)
US5175255A (en) * 1987-03-23 1992-12-29 Amgen Inc. Methods for purification of platelet-derived growth factor
US5190859A (en) * 1987-02-26 1993-03-02 Dana-Farber Cancer Institute, Inc. Purification of LFA-3
SE468653B (sv) * 1987-03-06 1993-02-22 Perstorp Biolytica Adsorbent foer isokratisk affinitetskromatografi
JPS6463599A (en) * 1987-05-01 1989-03-09 Xoma Corp Purification of immunoglobulin by selective anti-idiotype bond
ATE76974T1 (de) * 1987-07-14 1992-06-15 Univ Manchester Verfahren zur diagnose von infektionen, bei welchem lipopolyscaccharidantigene bestimmt werden.
CA1323567C (en) * 1987-10-05 1993-10-26 Gene R. Nathans Method for purification of antibodies
US5582862A (en) * 1988-04-04 1996-12-10 General Hospital Corporation Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin
US5372812A (en) * 1988-04-04 1994-12-13 The General Hospital Corporation Composition and method for acceleration of clot lysis
EP0937146A2 (en) * 1996-09-20 1999-08-25 The General Hospital Corporation Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin
EP3521311A1 (en) * 2008-04-11 2019-08-07 Chugai Seiyaku Kabushiki Kaisha Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
CA2819356C (en) 2010-11-30 2023-01-24 Chugai Seiyaku Kabushiki Kaisha Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly
SG10201609665PA (en) 2011-02-25 2017-01-27 Chugai Pharmaceutical Co Ltd FcɣRIIb-SPECIFIC Fc ANTIBODY
WO2013047748A1 (ja) 2011-09-30 2013-04-04 中外製薬株式会社 複数の生理活性を有する抗原の消失を促進する抗原結合分子
CA2857159C (en) 2011-11-30 2024-05-07 Chugai Seiyaku Kabushiki Kaisha Drug containing carrier into cell for forming immune complex
ES2899894T3 (es) 2014-12-19 2022-03-15 Chugai Pharmaceutical Co Ltd Anticuerpos anti-C5 y métodos de uso
NZ730607A (en) 2014-12-19 2022-07-01 Chugai Pharmaceutical Co Ltd Anti-myostatin antibodies, polypeptides containing variant fc regions, and methods of use
JP7141336B2 (ja) 2015-12-25 2022-09-22 中外製薬株式会社 抗ミオスタチン抗体および使用方法
CN109689099B (zh) 2016-08-05 2023-02-28 中外制药株式会社 用于预防或治疗il-8相关疾病的组合物
JP7191833B2 (ja) 2017-01-30 2022-12-19 中外製薬株式会社 抗スクレロスチン抗体およびその使用
CN110724204B (zh) * 2019-11-18 2021-10-22 广东菲鹏制药股份有限公司 Fc融合蛋白的纯化方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172124A (en) * 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
AU558931B2 (en) * 1981-02-26 1987-02-12 Unilever Plc A process and apparatus for the recovery of immunoglobulins
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
US4361509A (en) * 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies

Also Published As

Publication number Publication date
FI88403C (fi) 1993-05-10
FI834530A (fi) 1983-12-09
ES528001A0 (es) 1987-07-01
GB8332644D0 (en) 1984-01-11
ES8404858A1 (es) 1984-05-16
DK192191A (da) 1991-11-26
CA1209907A (en) 1986-08-19
EP0105359A1 (en) 1984-04-18
AT393386B (de) 1991-10-10
IT8320550A0 (it) 1983-04-12
CH672028A5 (es) 1989-10-13
AU622099B2 (en) 1992-04-02
ES8706964A1 (es) 1987-07-01
EP0105359A4 (en) 1984-08-20
WO1983003678A1 (en) 1983-10-27
ATA901983A (de) 1991-03-15
GB2128630B (en) 1986-08-28
IT1219779B (it) 1990-05-24
DK192191D0 (da) 1991-11-26
GB2128630A (en) 1984-05-02
FI834530A0 (fi) 1983-12-09
ES8506902A1 (es) 1985-08-01
ES521371A0 (es) 1984-05-16
AU7256987A (en) 1987-09-03
FI88403B (fi) 1993-01-29

Similar Documents

Publication Publication Date Title
ES528000A0 (es) Un procedimiento para la purificacion de un antigeno.
ES528627A0 (es) Un procedimiento para la preparacion de pirazolo-y piridazo-pirazolinas,-piridazinas y-diazepinas.
ES523858A0 (es) Un procedimiento para la preparacion de benzotienil benzofuranil o naftil-derivados.
ES525175A0 (es) Procedimiento para la formacion de un compuesto elastico.
ES501645A0 (es) Un procedimiento para la preparacion de 6-alquiliden-penamas.
ES506969A0 (es) Un procedimiento para la preparacion de pirimidinas sustitu-idas.
ES505464A0 (es) Un procedimiento para la preparacion de n-heterociclilaminocarbonil arilsulfonamidas.
ES520730A0 (es) Un procedimiento para la prepracion de nuevas benzolactamas.
ES507507A0 (es) Un procedimiento para la pre-paracion de imidazolilfenilami-dinas.
ES503307A0 (es) Un procedimiento para la preparacion de quinoxaliniloxieteres.
ES521318A0 (es) Un procedimiento para la preparacion de compuestos de bencimidazol.
ES506216A0 (es) Un procedimiento para la preparacion de 2-guanidino-4-heteroaril-tiazoles.
ES524346A0 (es) Procedimiento para la obtencion de poliaminas primarias.
ES522120A0 (es) Un procedimiento para la preparacion de 4-aril-4-piperidincarbinoles.
ES524456A0 (es) Un procedimiento para la preparacion de un poliester tri-otetrafuncional.
ES527780A0 (es) Un procedimiento para la preparacion de nuevas espiro-3-azolindionas.
ES523136A0 (es) Un procedimiento para la preparacion de un compuesto.
ES507919A0 (es) Un procedimiento para la preparacion de benzopiranotriazoles antialergicos.
ES514335A0 (es) Un procedimiento para la preparacion de guanidinas.
ES506034A0 (es) Un procedimiento para la preparacion de n-carboxialquil-dipeptidos.
ES523665A0 (es) Un aparato para la preparacion de un derivado de ditiolano.
ES518809A0 (es) Un procedimiento para la preparacion de un alergeno modificado.
ES521020A0 (es) Un procedimiento para la preparacion de lactamas pentaciclicas.
ES520076A0 (es) Un procedimiento para la preparacion de pirropirroles.
ES521933A0 (es) Un procedimiento para la fabricacion de un compuesto.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970505